Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Adaptive immune features of natural killer cells.

Sun JC, Beilke JN, Lanier LL.

Nature. 2009 Jan 29;457(7229):557-61. doi: 10.1038/nature07665. Epub 2009 Jan 11. Erratum in: Nature. 2009 Feb 26;457(7233):1168.

2.

DAP10- and DAP12-associated receptors in innate immunity.

Lanier LL.

Immunol Rev. 2009 Jan;227(1):150-60. doi: 10.1111/j.1600-065X.2008.00720.x. Review.

3.

Up on the tightrope: natural killer cell activation and inhibition.

Lanier LL.

Nat Immunol. 2008 May;9(5):495-502. doi: 10.1038/ni1581. Review.

4.

Evolutionary struggles between NK cells and viruses.

Lanier LL.

Nat Rev Immunol. 2008 Apr;8(4):259-68. doi: 10.1038/nri2276. Epub 2008 Mar 14. Review.

5.

Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways.

Coudert JD, Scarpellino L, Gros F, Vivier E, Held W.

Blood. 2008 Apr 1;111(7):3571-8. doi: 10.1182/blood-2007-07-100057. Epub 2008 Jan 15.

6.

Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells.

Yamanishi Y, Kitaura J, Izawa K, Matsuoka T, Oki T, Lu Y, Shibata F, Yamazaki S, Kumagai H, Nakajima H, Maeda-Yamamoto M, Tybulewicz VL, Takai T, Kitamura T.

Blood. 2008 Jan 15;111(2):688-98. Epub 2007 Oct 10.

7.
8.

DAP12: an adapter protein with dual functionality.

Takaki R, Watson SR, Lanier LL.

Immunol Rev. 2006 Dec;214:118-29. Review.

PMID:
17100880
9.

Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity.

Hyka-Nouspikel N, Phillips JH.

Immunol Rev. 2006 Dec;214:106-17. Review.

PMID:
17100879
10.

DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections.

French AR, Sjölin H, Kim S, Koka R, Yang L, Young DA, Cerboni C, Tomasello E, Ma A, Vivier E, Kärre K, Yokoyama WM.

J Immunol. 2006 Oct 15;177(8):4981-90.

11.

The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.

Lenac T, Budt M, Arapovic J, Hasan M, Zimmermann A, Simic H, Krmpotic A, Messerle M, Ruzsics Z, Koszinowski UH, Hengel H, Jonjic S.

J Exp Med. 2006 Aug 7;203(8):1843-50. Epub 2006 Jul 10.

12.

Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production.

Hesslein DG, Takaki R, Hermiston ML, Weiss A, Lanier LL.

Proc Natl Acad Sci U S A. 2006 May 2;103(18):7012-7. Epub 2006 Apr 20.

13.

NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.

Upshaw JL, Arneson LN, Schoon RA, Dick CJ, Billadeau DD, Leibson PJ.

Nat Immunol. 2006 May;7(5):524-32. Epub 2006 Apr 2.

PMID:
16582911
14.

Signal transduction in natural killer cells.

MacFarlane AW 4th, Campbell KS.

Curr Top Microbiol Immunol. 2006;298:23-57. Review.

PMID:
16329184
15.

Licensing of natural killer cells by host major histocompatibility complex class I molecules.

Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM.

Nature. 2005 Aug 4;436(7051):709-13.

16.

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.

Gasser S, Orsulic S, Brown EJ, Raulet DH.

Nature. 2005 Aug 25;436(7054):1186-90. Epub 2005 Jul 3.

17.

NK cell recognition.

Lanier LL.

Annu Rev Immunol. 2005;23:225-74. Review.

PMID:
15771571
18.

NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.

Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, Lenac T, Polic B, Bubic I, Kriegeskorte A, Pernjak-Pugel E, Messerle M, Hengel H, Busch DH, Koszinowski UH, Jonjic S.

J Exp Med. 2005 Jan 17;201(2):211-20. Epub 2005 Jan 10.

19.
20.

The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.

Lodoen MB, Abenes G, Umamoto S, Houchins JP, Liu F, Lanier LL.

J Exp Med. 2004 Oct 18;200(8):1075-81. Epub 2004 Oct 11.

Supplemental Content

Support Center